arrow
É

Étienne Dumont

glaxosmithkline united kingdom
H指数:22
被引数:2,494

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Phase 2a Pharmacokinetic, Safety, and Exploratory Efficacy Evaluation of Oral Gepotidacin (GSK2140944) in Female Participants with Uncomplicated Urinary Tract Infection (Acute Uncomplicated Cystitis)

在无并发症的尿路感染 (急性无并发症的膀胱炎) 的女性参与者中,口服Gepotidacin (GSK2140944) 的2a期药代动力学,安全性和探索性疗效评估

2020-06-2332
OAAI
A Novel Inhaled Dry-Powder Formulation of Ribavirin Allows for Efficient Lung Delivery in Healthy Participants and Those with Chronic Obstructive Pulmonary Disease in a Phase 1 Study
2020-04-2115
OAAI
A Phase IIa Study Evaluating Safety, Pharmacokinetics, and Antiviral Activity of GSK2838232, a Novel, Second-generation Maturation Inhibitor, in Participants With Human Immunodeficiency Virus Type 1 Infection
2019-11-2620
PREAI
Capabilities of GOSSAMER-1 derived small spacecraft solar sails carrying MASCOT-derived nanolanders for in-situ surveying of NEAs
2019-03-0116
OAAI
Microbiological Analysis from a Phase 2 Randomized Study in Adults Evaluating Single Oral Doses of Gepotidacin in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria gonorrhoeae
2018-12-0170
OAAI